SCHEMBL21961008

SCHEMBL21961008

Nc1cnn(CCN2CC3COCC3C2)c1N1CCOCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K14 Q99558 1/20 0.40
SMPD3 Q9NY59 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
PIK3CA P42336 4/20 0.33
AKT1 P31749 1/20 0.33
ADORA2A P29274 1/20 0.33
PIK3R1 P27986 2/20 0.32
SIGMAR1 Q99720 2/20 0.32
HDAC3 O15379 2/20 0.32
HDAC2 Q92769 2/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
KMT2A Q03164 1/20 0.32
MTOR P42345 2/20 0.32
GAA P10253 2/20 0.32
KDM4E B2RXH2 1/20 0.32
POLB P06746 1/20 0.31
PKM P14618 1/20 0.31
ABL1 P00519 1/20 0.31
BCR P11274 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21960938 0.79 SMPD3 (0.40) SMPD3L3MBTL1PIK3CAPIK3R1KMT2A
SCHEMBL21961349 0.75 SMPD3 (0.41) SMPD3L3MBTL1PIK3CAPIK3R1KMT2A
SCHEMBL14800128 0.68 PIM1 (0.36) KDM4EPKM
SCHEMBL21960921 0.66 ADORA2A (0.41) ADORA2ASIGMAR1HDAC3HDAC2CNR1
SCHEMBL16985426 0.66 MAPT (0.43) ADORA2ASIGMAR1HDAC3HDAC2CNR1
SCHEMBL16985287 0.65 SMPD3 (0.35) SMPD3SIGMAR1
SCHEMBL5103228 0.65 ADORA2A (0.44) ADORA2ASIGMAR1HDAC3HDAC2CNR1
Hydrochloric Acid SCHEMBL5098239 0.64 ADORA2A (0.43) ADORA2ASIGMAR1HDAC3HDAC2CNR1
SCHEMBL6068366 0.64 SMPD3 (0.39) SMPD3CNR2
Bromide SCHEMBL6068862 0.63 SMPD3 (0.38) SMPD3CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11136311-B2 Heteroaromatic derivatives as NIK inhibitors JANSSEN PHARMACEUTICA NV (BE) 2021-10-05 US disclosed
EP-3478675-B1 HETEROAROMATIC DERIVATIVES AS NIK INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2020-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11136311-B2 Heteroaromatic derivatives as NIK inhibitors NFKBIA, IKBKG, IKBKE MAP3K14 4/4885SMPD3 2363/4885L3MBTL1 2728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.